FY25 consensus $21.04. Raises FY25 revenue view to $35.8B-$36.6B from $35B-$36B, consensus $35.66B. Sees FY25 capital expenditures in the range of $2.2B-$2.3B. Share repurchases not to exceed $500M.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMGN:
- Notable companies reporting after market close
- These Are the Stocks Reporting Earnings Today – November 4, 2025
- Closing Bell Movers: Palantir down 3% after earnings
- AMGN Earnings this Week: How Will it Perform?
- Amgen’s Promising Phase 3 Study on Blinatumomab for Leukemia: What Investors Need to Know